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ABSTRACT
Pregenomic and Genomic Effects of 24,25(OH)2D3
by
Yang Zhang, Master of Science
Utah State University, 2015

Major Professor: Dr. Korry Hintze
Department: Nutrition, Dietetics, and Food Sciences
Vitamin D is hydroxylated to form several active metabolites, of these, 1,25dihydroxyvitamin D3 [1,25(OH)2D3] is the most studied stimulatory product. It is now
accepted that 1,25(OH)2D3 mediates its rapid actions on the control of phosphate
homeostasis through its membrane receptor 1,25D3-MARRS (membrane associated rapid
response steroid binding) protein. Another metabolite, 24,25-dihydroxyvitamin D3
[24,25(OH)2D3] has been reported to be inhibitory with respect to calcium and phosphate
absorption in intestine. Previous work in this laboratory has indicated that 24,25(OH)2D3
inhibits phosphate uptake in isolated intestinal cells and perfused duodenal loops and in
vivo. This thesis further tested the hypothesis that the actions of 24,25(OH)2D3 on
phosphate homeostasis are physiologically important. Catalase has been identified as a
binding protein for 24,25(OH)2D3. We determined the localization of catalase in the
presence and absence of steroid, monitored catalase mRNA levels related to gene
24,25(OH)2D3 gene transcription regulation. We studied the effects of the two isomers of
24,25(OH)2D3 on localization of catalase in chicken enterocytes over a time course of 15
sec to 60 min. It was demonstrated that 24R,25(OH)2D3 is the effective metabolite for
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catalase redistribution in vitro. We also studied the effects of vitamin D on catalase and
phosphate uptake in chicken intestinal cells. It was once again demonstrated that
24R,25(OH)2D3 is the effective metabolite for decreasing phosphate uptake and catalase
gene expression. These combined results lead us to conclude that 24,25(OH)2D3 is an
important hormone in phosphate homeostasis in chick intestinal epithelial cells.
(101 pages)
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PUBLIC ABSTRACT
Pregenomic and Genomic Effects of
24,25(OH)2D3
Yang Zhang

In the United States, the major dietary source of protein is poultry meat,
particularly chicken. Phosphorus absorption in chickens is a critical problem in poultry
production. It therefore is important to understand the cellular and molecular regulation
of phosphorous absorption in intestine to increase efficiency of the process. This would
provide the benefits of reducing feed costs and reducing phosphorous excretion, thereby
contributing to the sustainability of agriculture in the United States. Therefore, the focus
of this thesis is determining the effect of vitamin D metabolites involved in phosphate
homeostasis using the chicken as a model.
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CHAPTER 1
LITERATURE REVIEW

Outline
This literature review will begin with an overview of vitamin D history and
background. Next, metabolic mechanisms of vitamin D will be discussed and introduced.
Then, a more focused look at different vitamin D metabolites and their receptors will be
presented; phosphate and calcium homeostasis will also be addressed. Last, an overview
of catalase metabolism and applications will be addressed.
Background
In the past several years, vitamin D has received enormous attention, specifically
at the public health level, mainly because of the discovery of its many unexpected health
benefits. It is now realized that vitamin D is important not only for mineralization and
skeletal growth but also in regulation of the immune system, the parathyroid gland, the
skin, and in cancer prevention. Since the initial discovery of vitamin D in the early 20th
century, vitamin D was recognized not only for its major medical importance by
eliminating rickets as a major medical problem, but also had received a bad reputation
because of outbreak of idiopathic hypercalcemia after World War II attributed to food
fortification with vitamin D [1]. In the United States and Canada, there is a campaign to
increase the awareness of the benefits of vitamin D as well as to increase the
recommended daily allowance of vitamin D [2]. However, vitamin D is potentially toxic
when provided in large amounts [3]. A report in 2007 indicates 10,000 units of vitamin

2
D3 per day is safe for 6 months [4] (NOAEL: no observed adverse effects level). In 2011,
the Food and Nutrition Board set the upper limit (UL) for vitamin D3 to 4,000 IU per day,
simply calculated from the NOAEL by dividing by a safety factor (which is 2.5 in
vitamin D’s case). This is an important start, and the recommendation probably will be
changed in the years to come. It is important to note that vitamin D is fat-soluble so it is
stored in the adipose tissue and accumulation of vitamin D could possibly result in
toxicity.
History and Metabolic Mechanisms
Sir Edward Mellanby found the first evidence of the existence of vitamin D in
1919 [5]. He was able to produce rickets in dogs between 5 and 8 weeks by feeding them
one of four natural diets and keeping them indoors, and cure the disease with cod liver oil,
which is also rich in vitamin A. So there was uncertainty whether it was vitamin A that
treated rickets or some new factor. In the same year, Huldshinsky discovered that rickets
in chicken could be cured by ultraviolet light [6], which might be the first lead that
vitamin D is not really a traditional vitamin. In 1922, McCollum [7] demonstrated that
cod liver oil contained another vitamin that is responsible for bone mineralization, which
he named “vitamin D”. Scientists have demonstrated that ultraviolet light is capable of
converting an inactive substance into an active substance that could cure rickets [8, 9],
thus led to the conclusion that the skin is of major importance in the production of
vitamin D.
Increasing the amount of meat on chicken and turkeys, which requires sufficient
support of bone structure, has always been a goal in poultry production. To date,
strategies for improving bone strength have included increasing dietary calcium and
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phosphate, as well as vitamin D (calciferol), which is not really a strict vitamin but the
pre-hormone that serves as the parent compound for the production of three active
metabolites:

25-hydroxyvitamin

D3 ,

1,25-dihydroxyvitamin

D3 ,

and

24,25-

dihydroxyvitamin D3. Discovered in 1919-1924, vitamin D is a fat-soluble antirachitic
factor, and it is naturally present in very few foods: a small amount in milk and eggs, and
relatively large amounts in fatty fish. The actual vitamin D content of fortified milk is not
the same as the stated 400 IU per liter [10]. Vitamin D is primarily produced when
ultraviolet rays (action spectrum 280-320 nM or UVB) in sunlight triggers vitamin D
synthesis endogenously under the skin. Today, many populations are still at risk of
vitamin D inadequacy despite the fortification of vitamin D in foods and the ability of the
body to synthesize the vitamin, these include breastfed infants [11], older adults [12],
people with limited sun exposure, people with dark skin [13], people with fat
malabsorption [14] and people who are obese [15] or who have undergone gastric bypass
surgery [16]. In the past, vitamin D was thought to only influence only bone diseases
such as rickets and osteoporosis through regulation of active transport of calcium in
enterocytes [17]. However, recently vitamin D has been accepted as a major player in
overall human health [18], playing a role in chronic diseases such as arthritis, obesity,
cancer, auto-immune diseases, cardiovascular diseases, and diabetes [19]. Vitamin D has
been shown to influence virtually every cell in the human body, and receptors that
respond to vitamin D have been found in nearly every cell type [19]. One recent study
has shown that a large cohort of women age 65 and older experience low vitamin D
levels, which possibly contributed to mild weight gain [20]. An association between
vitamin D and cancer was first proposed in 1980 based on an ecological study of colon
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cancer mortality rates and annual sunlight levels in the United States [21]. Currently,
researchers have shown that higher vitamin D levels decrease the risk of 15 different
types of cancer [22]. In an effort to understand how to use vitamin D as a weapon to
combat chronic diseases, the underlying mechanisms involved with calcium and
phosphate homeostasis that is at the core of cell signaling, growth and proliferation must
be understood.
Our understanding of how vitamin D mediates biological responses has entered a
new era. Phosphorus and calcium are two of the most abundant trace elements in the
body and must be regulated in order to maintain proper cellular functions. Vitamin D
promotes calcium absorption and maintains adequate serum calcium and phosphate
concentrations to enable normal bone mineralization, growth and remodeling [23].
Vitamin D modulates cell growth, neuromuscular and immune function, and reduces
inflammation. It also regulates expression of many genes encoding proteins that regulate
cell proliferation, differentiation, and apoptosis [23].
Vitamin D Synthesis
The following steps occur in vitamin D synthesis [17]: in the epidermis there is
abundant 7-dehydrocholesterol, when the skin is exposed to the UVR, 7dehydrocholesterol is photolyzed to pre vitamin D3. Vitamin D3 (cholecalciferol, from
animal sources) is a secosteroid since the B ring of 7-dehydrocholesterol is broken from
photolysis, which in turn gives it a cis-triene structure [24]. The cis-triene structure gives
vitamin D3 its unique ultraviolet absorption at 265 nm with a minimum at 228 nm. With
continued UVR exposure, vitamin D3 is converted to biologically inactive lumisterol and
tachysterol [25]. The formation of lumisterol and tachysterol is reversible and can be
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converted back to vitamin D3 if needed. This explains the lack of vitamin D3 toxicity
through prolonged sun exposure. After formation, vitamin D3 is transported to the liver
and is enzymatically hydroxylated to 25-hydroxyvitamin D3 [calcidiol, 25(OH)D3, the
major circulating form of the vitamin] after binding to its carrier protein-vitamin Dbinding protein (DBP) which does not bind pre vitamin D3 [26]. Hydroxylation is
catalyzed by a microsomal cytochrome P450 enzyme, type I mitochondrial cytochrome
P450 oxidases, CYP2R1 or the mitochondrial cytochrome P450 CYP27A1, which
utilizes NADPH and molecular oxygen to catalyze the hydroxylation reaction [27].
25(OH)D3 quickly enters the circulation with normal circulating levels between 25
nmol/L to 200 nmol/L, and it has a half-life of about 15 days [28]. 25(OH)D3, bound to
DBP, is then transported to the kidneys and is finally hydroxylated by 1α-hydroxylase
(also termed CYP27B1 or P450C1, an enzyme that is highly expressed in renal proximal
tubules [29]) at the C1 position to hormonally active 1,25(OH)2D3. This occurs when
serum levels of calcium and phosphate are low. The serum levels of 1,25(OH)2D3 range
from 75 pmol/L to 200 pmol/L and it has a serum half-life of 10-24 hours [30].
Regulation of CYP27B1 is controlled by PTH, and fibroblast growth factor (FGF)-23
which inhibits expression respectively [25]. By contrast, when serum levels of calcium
and phosphate are high, suppression of 1α-hydroxylase by high levels of circulating
calcium or phosphate stimulates another hydroxylase (CYP24 or P450C24) that converts
25(OH)D3 to 24,25-dihydroxyvitamin D3 (24,25(OH)2D3). Both positive (PTH, estrogen,
and growth hormone) and negative (1,25(OH)2D3, calcium) regulators of the renal
hydroxylases have been identified, and acute regulation of renal 1,25(OH)2D3 production
is mediated through the adenylate cyclase and protein kinase C pathways [31, 32].
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Vitamin D and Calcium Transport
When intestinal calcium transport was measured in vitamin D-deficient rats given
a dose of vitamin D3, a 12-hour period was required for a response [33]. This coupled
with the observation that it took 24h before intestinal calcium absorption reached a
maximum level led to the belief that vitamin D3 needed to be activated before it could
carry out its physiological functions on calcium metabolism [34, 35]. In a study that
provided radiolabeled vitamin D3 to vitamin D-deficient rats caused the disappearance of
radiolabeled vitamin D3 and the appearance of polar metabolite fractions [34].
Researchers observed that the polar metabolite fraction stimulated intestinal calcium
transport much more rapidly than vitamin D3. In a subsequent study, pigs were given
vitamin D3, blood was collected and a lipid extraction followed by several
chromatography steps yielded a vitamin D3 metabolite that was about fourfold more
potent than vitamin D3 in stimulating intestinal calcium transport. It was structurally
identified as 25-hydroxyvitamin D3 [36]. This observation and the finding that the
hydroxylated metabolite took 12h to maximize intestinal calcium absorption in vitamin D
deficient rats [17] and supported the belief that 25(OH)D3 is the circulating active form of
vitamin D3. It was then reported [37] that a polar metabolite of vitamin D3 in the intestine
that was distinct from 25(OH)D3 also existed. The further modified metabolite 1,25dihydroxyvitamin D3 [1,25(OH)2D3, also known as calcitriol] was isolated from chicken
intestines, and the molecular attributes were revealed by mass spectrometry, ultraviolet
absorption spectrophotometry, and specific chemical reactions [38]. Once the structure
was discovered, it took 2 years and a 21 step synthesis to chemically synthesize
1,25(OH)2D3, yielding about 1mg final product out of 1kg starting materials [17]. The
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configuration of the hydroxyl group on position 1 was discovered-1α,25(OH)2D3 (the
natural metabolite) and 1ß,25(OH)2D3 [39]. The hydroxylation of the 1α position is
strongly feedback-regulated and is one of the major endocrine systems regulating plasma
calcium and phosphorus concentrations.
Phosphate and Calcium Homeostasis
Homeostatic regulation of phosphate and calcium and their effects on the intestine,
kidneys and bone are maintained by several key hormones, which includes the vitamin D
metabolites, calcitonin, fibroblast growth factor-23 (FGF-23), and parathyroid hormone
(PTH) [40-42]. When serum phosphate or calcium levels are low, the parathyroid glands
synthesize PTH, which acts on the kidneys to decrease phosphate reabsorption, to
increase calcium reabsorption, and to stimulate synthesis of 1α-hydroxylase to convert
circulating 25(OH)D3 into 1,25(OH)2D3. Then 1,25(OH)2D3 travels through the blood
stream to enhance phosphate and calcium absorption in the intestine. Both PTH and
1,25(OH)2D3 simultaneously act on osteoclasts to induce bone resorption thereby
increasing circulating phosphate and calcium levels to normal ranges.
Abnormally high serum phosphate or calcium levels also trigger hormonal
regulation to maintain normal circulating ranges. Elevated phosphate levels stimulate
FGF-23 synthesis in bone [43, 44] which act on the kidneys to decrease 1,25(OH)2D3
synthesis by inhibiting 1α-hydroxylase activity, increasing phosphate excretion,
decreasing phosphate reabsorption which inhibits synthesis of phosphate transporters
[45]FGF-23 also acts by decreasing intestinal phosphate absorption which acts to
internalize phosphate transporters, and stimulate 24-hydroxylase activity to synthesize
24,25(OH)2D3 [46-49]. Elevated calcium levels stimulate calcitonin synthesis in the
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thyroid glands [50, 51] which acts on bone to inhibit bone resorption [52, 53] and inhibit
PTH synthesis in the parathyroid glands. Inhibition of PTH synthesis allows increased
synthesis of 24-hydroxylase in the kidneys to convert 25(OH)D3 into 24,25(OH)2D3
which inhibits calcium transport in the intestine [40, 54]. Directly or indirectly,
25(OH)D3, calcitonin, FGF-23, and PTH act on 1,25(OH)2D3 and 24,25(OH)2D3
synthesis to regulate calcium or phosphate reabsorption and excretion in the kidneys,
resorption from bone, or absorption in the intestine to maintain homeostatic levels of both
microminerals.

9

Figure 1.1 Schematic presentation of phosphate homeostasis. The kidney converts 25hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 when the organism is deficient in
vitamin D, phosphate, and/or calcium. Hypocalcemia also signals the parathyroid glands
to release parathyroid hormone (PTH), which stimulates 1α-hydroxylation of 25(OH)D3.
1,25(OH)2D3 stimulates absorption of minerals from the intestine and reabsorption from
the kidney. Fibroblast growth factor 23 (FGF-23) inhibits the formation of 1,25(OH)2D3
and promotes phosphaturia. 24,25-dihydroxyvitamin D3, which blocks stimulated uptake
of minerals from the intestine and PTH release from the parathyroid glands.

10

Figure 1. 1 Structure of vitamin D and its metabolites
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Figure 1. 2 Regulation of PTH and 1,25(OH)2D3 in calcium homeostasis

12
25(OH)D3
25-hydroxyvitamin D3, a pre-hormone activated through the action of 25hydroxyvitamin D3 1 hydroxylase, was once thought to have no biological activity of its
own. However, evidence has been found to prove the opposite. Early reports suggested a
possible physiological role in egg hatchability [55, 56]. The metabolite is 1.4 times more
active than vitamin D3 in curing rickets in rats and chicks determined by the bone ash
assay [57]. It stimulates calcium transport in the intestine and bone resorption in vivo
more rapidly than cholecalciferol does [57]. A stimulation of bone resorption in tissue
culture in vitro was observed with 25(OH)D3 [58]. An enhancement of calcium transport
in isolated duodenal loops was observed after perfusion with 100 nM 25(OH)D3
compared with controls [59, 60]. 25(OH)D3 has also been observed to suppress
parathyroid hormone synthesis [61]. Gene expression analysis indicated that 25(OH)D3
induced 25-hydroxyvitamin D3 24-hydroxylase mRNA in a dose and time dependent
manner [62]. 25(OH)D3 has been shown to lower the risk of colorectal cancer [63], and
has been associated with increasing overall survival in early stage non-small cell lung
cancer (NSCLC) [64].
Effect of 1,25(OH)2D3 on Phosphate Absorption
1,25(OH)2D3, also known as calcitriol, stimulates the active transport of
phosphorus in the small intestine when plasma or serum phosphate levels are low. When
there is a vitamin D deficiency, phosphate transport is impaired and bone resorption
occurs. A continued deficiency results in hypophosphatemia, rickets or osteomalacia [45].
Studies [46, 65] have demonstrated that chick intestinal cells can be rapidly stimulated to
take up phosphate through a signal transduction pathway mediated by protein kinase C
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(PKC). This mechanism can be activated by the 1,25D3-MARRS receptor, which is
identical to protein disulfide-isomerase A3 (PDIA3) [65]. In rats [66], membrane initiated
signaling relies on both cell surface VDR and the 1,25D3-MARRS receptor. 1,25(OH)2D3
was shown to enhance phosphate uptake within 1 min suggesting that stimulation of the
uptake process occurs through a pre-genomic pathway [67-70], not involving gene
regulation which usually occurs over a period of several hours to days. That led
researchers to identify a plasma membrane receptor to explain the rapid effects [71].
Membrane Receptors for 1,25(OH)2D3
In rat enterocytes, Lieberherr et al. [72] were the first to demonstrate the need for
a membrane receptor in mediating phosphoinositide metabolism. Traditionally,
1,25(OH)2D3 has been shown to act through a nuclear vitamin D receptor [73] (VDR).
Now, a membrane receptor called the 1,25(OH)2D3 membrane associated, rapid response
steroid-binding receptor (1,25D3-MARRS) has also been identified [40, 41, 71, 73]. The
role of this protein is to facilitate the rapid effects of 1,25(OH)2D3-mediated calcium and
phosphate absorption and uptake in isolated chick enterocytes and transport in perfused
duodenal loops [46, 74, 75]. The 1,25D3-MARRS receptor was subsequently reported to
be identical to ERp57/GR58/PDIA3 and has been characterized through prosite analysis
[74, 75] as containing several PKC and casein kinase phosphorylation sites, a Rel
homology domain (RHD), and two thioredoxin folds. The latter binding sites allow it to
interact with other proteins including catalase [65, 71].
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Figure 1.4 Model for interaction between 1,25D3-MARRS receptor and catalase. Upon
binding 1,25(OH)2D3, the 1,25(OH)2D3-MARRS receptor dimerizes and initiates signal
transduction through PKA for enhanced calcium uptake and PKC for enhanced phosphate
uptake. Feedback inhibition of this stimulatory pathway is initiated when 24,25(OH)2D3
binds to catalase, thereby decreasing enzymatic activity. The increased H2O2 levels are
known to inhibit stimulated ion uptake. Mechanistically, this occurs through oxidation of
the 1,25(OH)2D3-MARRS receptor to decrease 1,25(OH)2D3 binding, and subsequent
signal transduction, as well as directly inhibiting hormone-stimulated PKC activity.
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Metabolite

Site of activation

25(OH)D3

Liver

1,25(OH)2D3

Kidney

24,25(OH)2D3

Kidney

Proposed action
Increased Ca2+
uptake in rat and
chick duodena
Increased
phosphate uptake
and transport in
intestine
Decreased
phosphate uptake
in presence of
1,25(OH)2D3 in
intestine

Table 1. 1 Vitamin D metabolite action summary

Reference
[70, 76]

[46]

[40]
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Mechanism of action for 1,25(OH)2D3
The effects of 1,25(OH)2D3 are mediated through two mechanisms:
1.) Genomic actions – the cellular actions of this hormone are due to the binding of
the hormone to a nuclear vitamin D receptor (nVDR), and represents a slow
mechanism since it is involved with gene transcription and protein synthesis, for
example in bone matrix [77]. This ligand-receptor complex interacts with the
retinoid X receptor, and regulates the expression of approximately 500 genes [18].
The 1,25D3-MARRS receptor has also been found to translocate to the nucleus
upon binding hormone and associate with heterochromatin, suggesting gene
regulation [78].
2.) Pre-genomic or rapid response actions – there are some cellular responses that are
rapidly stimulated by 1,25(OH)2D3 and cannot be explained by the slow
mechanism via VDR. These actions are mediated through the 1,25D3-MARRS
receptor. The signal transduction pathway involved in the rapid stimulation of
mineral transport can be activated through protein kinase C, phospholipase C,
protein kinase A and mitogen activated protein kinase [79, 80].
Effect of 24,25(OH)2D3 on phosphate uptake
While 1,25(OH)2D3 stimulates the rapid transport of calcium and phosphate as
illustrated in Table 1, 24,25(OH)2D3 inhibits such stimulation [40, 46, 54]. Hormonestimulated phosphate uptake in chick intestinal cells is initiated by ligand binding to the
1,25D3-MARRS receptor and is inhibited by 24,25(OH)2D3. Since 24,25(OH)2D3 does
not compete for binding the 1,25D3-MARRS receptor [81], in order to elucidate how
24,25(OH)2D3 effects inhibition, a cellular binding protein with Kd = 7 nM for
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24,25(OH)2D3 was purified [82] and sequenced and subsequently identified as catalase
[83]. The majority of binding material was vesicular [82] while specific binding was
found at the cell surface [84]. A functional consequence of 24,25(OH)2D3 binding to
catalase was found to be a decrease in enzyme activity, accompanied with an increase in
H2O2 production [85], beyond basal levels [86]. Oxidation of the 1,25D3-MARRS
receptor and inhibition of binding to [3H]1,25(OH)2D3 was found to be one possible
mechanism of inhibition [85]. Antioxidants were found to block the inhibitory actions of
24,25(OH)2D3, whereas pro-oxidants were found to mimic the inhibitory actions of the
steroid [48].
Membrane receptor for 24,25(OH)2D3
As stated previously, the metabolite 24,25(OH)2D3 is produced when an animal is
calcium, phosphate, and vitamin D replete, and represents an important feedback loop to
provide a protective mechanism against excess 1,25(OH)2D3 [40, 46, 87, 88]. Sequence
analysis of a 24,25(OH)2D3 binding protein was performed and five regions of homology
was found with enzyme catalase [83]. Studies were then undertaken to determine whether
24,25(OH)2D3 treatment would affect catalase activity. The results showed a timedependent decrease in catalase activity in isolated intestinal epithelial cells after the
addition of physiological levels of 24,25(OH)2D3 (6.5 nM), whereas 1,25(OH)2D3 did not
have a similar effect [85]. Another study was then performed to test whether preincubation of cell suspensions with low concentration of hydrogen peroxide would inhibit
the rapid 1,25(OH)2D3-stimulated uptake of
addition of 130 pM 1,25(OH)2D3,
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P. The results showed that after the

P uptake reached 135% of controls; whereas a 10-

min pre-incubation of cells with 50 µM H2O2 abolished the increase [85]. The effect of
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hydrogen peroxide was shown to be reversible. The catalase inhibitor 3-amino-1,2,4triazole [89] mimicked the effects of 24,25(OH)2D3 since it blocked 1,25(OH)2D3stimulated phosphate uptake [90]. Pre-incubation of chicken enterocytes with either a
commercially available anti-catalase antibody [83] prevented the inhibitory actions of
24,25(OH)2D3 [48].
Mechanism of actions for 24,25(OH)2D3
One mechanism for the inhibitory effects of 24,25(OH)2D3 could be through
oxidation of the thioredoxin domains of the 1,25D3-MARRS receptor. The
24,25(OH)2D3-mediated decrease in [3H]1,25(OH)2D3 binding to MARRS was not
observed when incubated with the strong reducing agent dithiothreitol [65]. Nemere et al.
have previously reported that 24,25(OH)2D3 does not bind to the 1,25D3-MARRS
receptor [81]. Chicken enterocytes were incubated for 5, 10, 20 or 30 min with the
addition of a physiological level (6.5 nM) 24,25(OH)2D3. Cells were collected by
centrifugation, then homogenized, then incubated with [3H]1,25(OH)2D3 in the absence
(total binding) or presence (nonspecific binding) of a 200-fold molar excess of unlabeled
steroid. The result indicated no classical VDR binding detection [71]. Since hydrogen
peroxide could also influence the signal transduction pathway, isolated intestinal cells
were incubated with phorbol ester after pre-incubation with hydrogen peroxide. The
results showed that hydrogen peroxide inhibited the phorbol stimulation of 32P uptake and
PKC signaling in response to 1,25(OH)2D3 [91]. The ability of 24,25(OH)2D3 to decrease
catalase activity was determined by follow-up studies. A decrease in catalase specific
activity and catalase protein levels were observed after primary cultures of chick
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enterocytes after exposure to 24,25(OH)2D3 for 5 h [92]. The model depicted in Figure
1.3 was formulated based on these observations and data.
Catalase
The discovery of catalase (H2O2: H2O2-oxidoreductase, EC 1.11.1.6) was first
hinted at 1811 when the French chemist who discovered hydrogen peroxide (H2O2),
Louis Jacques Thenard [93], suggested its breakdown is caused by an unknown substance.
In 1900, the German chemist Oscar Loew found catalase in both plants and animals, and
was the first to name it catalase [94]. In 1937 ， catalase from bovine liver was
crystallized by James B. Sumner and Alexander Dounce, achieving one of the first
successful crystallizations of an intracellular enzyme [95], and the molecular weight was
determined in 1938, catalase is a tetramer with a total molecular weight of approximately
24kDa. [96].
Physiological importance and molecular mechanism
Oxygen is necessary for life but also produces free radicals that can damage cell
membranes, proteins and DNA. Hydrogen peroxide is a naturally occurring but
destructive waste product of all oxygen-dependent organisms. It is produced in the
human body when fatty acids are converted to energy, and when white blood cells attack
and kill bacteria. The optimum pH for human catalase is approximately 7.0 [97], and can
dispose of five times more H2O2 than glutathione peroxidase [98]. Hydrogen peroxide
can freely cross membranes and generate the most reactive free radicals, hydroxyl
radicals [99]. Hydrogen peroxide produced by the glucose oxidation system and can
damage nuclear and mitochondrial DNAs [100]. Catalase, which is normally found in the
peroxisomes [101] of nearly all aerobic cells, prevents this naturally occurring and
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constantly generating hydrogen peroxide from harming the cells during these processes
[102-104]. Catalase is a biological bi-functional catalyst, like superoxide dismutase (SOD)
and glutathione peroxidase, is produced naturally within the body. Catalase works
flawlessly with superoxide dismutase system to prevent free radical damages to cells,
preventing cell death. SOD converts the dangerous superoxide radical to hydrogen
peroxide, which catalase then rapidly converts to harmless water and oxygen [98].
Catalase is a tetrametric enzyme consisting of four identical subunits of 60 kDa,
each containing a heme group and a NADPH binding site [105, 106]. The ferric oxidation
state allows the enzyme to react with H2O2, and four tightly bound NADPH molecules to
prevent the enzyme from inactivation by H2O2 [106] [107]. Catalase exerts its functions
in two ways depending on the concentration of H2O2: 1) catalytic reaction 2H2O2 à2H2O
+ O2: decomposition of H2O2 to give H2O and O2 if the concentration of H2O2 is high; 2)
peroxidatic reaction ROOH + AH2 à H2O + ROH + A: oxidization of substrate if the
concentration of H2O2 is low and in the presence of a suitable hydrogen donor (i.e.,
ethanol, methanol, phenol) [108]. The peroxidase function is probably the result of gene
duplication of an ancestral peroxidase gene [109] and is found in bacteria and fungi [110].
The concentration of catalase varies in different tissues, and differs from species to
species. The highest concentration from tissues is found in the liver. A higher level of a
catalase substrate in the cell leads to higher levels of catalase. This gene is conserved in
human, chimpanzee, dog, mouse, rat, chicken, fruit fly, C. elegans and rice. It has been
theorized that one of the primary reasons cells age is the damage to DNA caused by free
radicals and oxidizing agents [111-114] such as hydrogen peroxide, and that elevating
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levels of the body’s endogenous antioxidants – SOD, catalase, and glutathione peroxidase
– could both improve human health and increase human lifespan [115-118].
Hypothesis and Objectives
The overall hypothesis is 24R,25(OH)2D3 is the active metabolite in phosphate
homeostasis by using immunological techniques to determine the localization of catalase
and by monitoring catalase mRNA levels to determine if 24,25(OH)2D3 regulates gene
transcription.
Part I – Effect of 24,25-dihydroxyvitamin D3 on localization of catalase in chick
enterocytes.
Hypothesis: 24R,25(OH)2D3 is the effective metabolite for catalase redistribution as
judged by confocal microscopy.
Objectives:
1.) To determine the localization of catalase;
2.) To evaluate whether punctuate staining in the nucleus arose from the
redistribution of cell surface catalase.
Part II – Effects of vitamin D on catalase expression and phosphate uptake in
chicken intestinal cells.
Hypothesis: 24R,25(OH)2D3 is the effective metabolite for decreasing
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P uptake and

catalase gene expression.
Objectives:
1.) To determine the effects of 24R,25(OH)2D3 on 32P uptake in chick enterocytes;
2.) To determine whether 24R,25(OH)2D3 has any effect on catalase gene expression;
3.) To evaluate whether 24R,25(OH)2D3 has effect on catalase protein expression.
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CHAPTER 2
EFFECT OF 24,25-DIHYDROXYVITAMIN D3 ON LOCALIZATION OF
CATALASE IN CHICK ENTEROCYTES

Abstract
The vitamin D metabolite, 24,25(OH)2D3 has been reported to have hormonal
activity. Catalase has been reported to be a binding protein for 24,25(OH)2D3, based on
sequence analysis of the protein isolated on the basis of specific binding of the
metabolite. In the current work, we report that 24R,25(OH)2D3, not 24S,25(OH)2D3 is the
effective metabolite for catalase redistribution as judged by confocal microscopy. We
have used male chick intestinal cells treated with either vehicle, 24R,25(OH)2D3,
24S,25(OH)2D3 or 1,25(OH)2D3 to determine the localization of catalase. Confocal
microscopy analyses showed punctate staining, on the cell surface and in the cytoplasm
of cells treated with vehicle, 24R,25(OH)2D3, 24S,25(OH)2D3 or 1,25(OH)2D3 for all
time points tested. Cells treated with 24R,25(OH)2D3 showed punctuate staining of
catalase inside the nucleus. Western analysis confirmed that the punctuate staining in the
nucleus arose from the redistribution of cell surface catalase. Western analysis also
indicated 24S,25(OH)2D3 treatment resulted in redistribution of catalase to the nucleus,
but to a lesser extent than treatment with 24R,25(OH)2D3. By understanding the
molecular and cellular actions of 24,25(OH)2D3 in chick intestine, progress will be made
in enhancing phosphate and calcium absorption in animals to supply the minerals for
adequate bone growth, and phosphate in manure of production animals could be
diminished.
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Introduction
Vitamin D was discovered in 1922 and has been categorized as a pre-hormone
ever since, based on the fact that the utilization of most vitamin D in higher animals
undergoes a photochemical process. Activation of vitamin D starts in the liver with the
production of major circulating metabolite 25-hydroxyvitamin D3 [25(OH)D3], followed
by hydroxylation in the kidneys to yield two metabolites, either 1,25-dihydroxyvitamin
D3 [1,25(OH)2D3] made when phosphate and calcium levels are low or 24,25dihydroxyvitamin D3 [24,25(OH)2D3] made when phosphate and calcium levels are high.
24,25-dihydroxyvitamin D3 is no longer considered an inactive hormone. Earlier studies
showed that in order to reach normal chick hatchability [1] and bone formation [2], both
1,25(OH)2D3 and 24,25(OH)2D3 were necessary. While 1,25-dihydroxyvitamin D3
stimulates the rapid transport of calcium and phosphate in both perfused chick duodenal
loops and isolated enterocytes, 24,25-dihydroxyvitamin D3 inhibits such stimulation [3,
4]. In osteoblasts and osteosarcoma cells, 1,25(OH)2D3 has been found to have a rapid
effect on calcium-channel-opening, while 24,25(OH)2D3 was found to inhibit this nonnuclear effect [5-7]. In chick intestinal cells, 1,25(OH)2D3 has been found to have an
acute, non-nuclear effect on phosphate transport, and 24,25(OH)2D3 has been found to
inhibit the reaction [8], with no effect on parathyroid hormone (PTH) stimulated
phosphate transport [9]. In perfused chick duodenal loops, 24,25(OH)2D3 inhibits the
rapid stimulation of phosphate transport [8] mediated by 1,25(OH)2D3, as well as calcium
transport [10].
In chick intestinal cells, hormone-stimulated phosphate uptake is initiated by
ligand binding to the 1,25D3-membrane associated, rapid response steroid-binding
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receptor – 1,25D3-MARRS [11], also known as ERp57/GR58/PDIA3. The ability of
24,25(OH)2D3 to inhibit 1,25D3-MARRS receptor activation of protein kinase A and C
activities was found in chick intestine [12] and kidney [4], which indicates the existence
of a specific binding protein for 24,25(OH)2D3. Percoll gradient analysis revealed
lysosomal fractions to have the highest [3H]24,25(OH)2D3 binding activity [10]. In order
to explain how 24,25(OH)2D3 works to affect inhibition, a cellular binding protein (66
kDa) was isolated, purified [10] and sequenced [13]. It was found to have a binding
constant of 7 nM for 24,25(OH)2D3, and identified as catalase using Edman degradation
techniques [13]. The enzyme catalase is sensitive to cell signaling molecules [14]. It was
found that the inhibitory action of 24,25(OH)2D3 is caused by a decrease in catalase
activity in both chick intestine [15, 16] and kidney [12], accompanied by an increase in
H2O2 production [13]. Thus, one possible mechanism for the inhibitory action would be
the oxidation of thioredoxin domains in 1,25D3-MARRS receptor that occurred after 10
min of exposure [15], accompanied by a loss of binding activity. However, studies [15]
showed a time-dependent decrease with either 24,25(OH)2D3 or H2O2 treatments after 5
minutes of incubation, indicating another mechanism because 24,25(OH)2D3 does not
compete with 1,25(OH)2D3 for MARRS binding.
In intestinal cells, studies showed 1,25D3-stimulated phosphate uptake is
mediated by PKC signaling [3], and 24,25(OH)2D3 seems to abolish that effect [10].
Thus, another possible mechanism would be the affecting the signal transduction pathway
[17].
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In this study, chick enterocytes were used to determine the localization of catalase
in response to different vitamin D steroid hormones. Western analysis was performed to
verify the results from confocal microscopy.
Experimental
Animals
All surgical procedures were approved by Utah State University Institutional
Animal Use and Care Committee. White leghorn cockerels were obtained on the day of
hatch (Privett Hatchery, Portales, NM) and raised on a commercially available vitamin Dreplete diet (Nutrena Feeds, Murray, UT) generally for 3-7 weeks prior to
experimentation. On the day of use, chicks were anesthetized with anhydrous ethyl ether
(Fisher Scientific, Fair Lawn, NJ). The abdominal cavity was surgically opened and the
duodenal loop was removed to ice-cold 0.9% saline solution and chilled for 15 min. The
pancreas was excised from the duodenal loop and discarded. The duodenal loop was
everted and rinsed three times in chilled saline solution.
The chick intestinal cells were isolated with citrate chelation media (96 mM
NaCl, 27 mM Citrate Anhydrous, 1.5 mM KCl, 8 mM KH2PO4, 5.6 mM Na2HPO4, pH
5.0 - the acidic pH promotes viability and retention of morphology) [3, 18]. The cells
were collected by low speed centrifugation (500 x g, 5 min, 4ºC), and cell pellets were
resuspended in a small volume of Gey’s balanced salt solution (GBSS, containing 119
mM NaCl, 4.96 mM KCl, 0.22 mM KH2PO4, 0.84 mM NaHPO4, 1.03 mM MgCl2•6H2O,
0.28 mM MgSO4•7H2O, 0.9 mM CaCl2, pH 7.3). Aliquots of the cell suspension (0.4 ml)
were pipetted into 35 mm-plastic Petri dishes (Falcon, Scientific Products; Franklin
Lakes, NJ) containing 1.5 ml of RPMI 1640 medium and antibiotics (100 units/ml
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penicillin, 100 mg/ml streptomycin, Sigma Chemical Co, St. Louis, Mo). The cells were
incubated overnight in the absence of serum at 37ºC with 5% CO2/ 95% air to promote
cell adhesion.
Confocal Microscopy
The following morning, media were replaced with 0.1% BSA in GBSS (GBSSBSA, Bovine Serum Albumin, Sigma, St. Louis, MO) and cells treated either with
vehicle (0.01% ethanol) or hormone for 15 sec to 60 min (15s, 30s, 7 min, 10 min, 15
min, 25 min, 30 min, 40 min, 50 min, 60 min). At the end of each time point, media were
replaced with 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA), 3%
sucrose in PBS (phosphate buffered saline) and fixed for 30 min. After washing with
0.1% PBS-BSA, cells were incubated with 0.05% NaBH4 in PBS for 5 min to eliminate
auto-fluorescence in the brush border, then washed and permeabilized with 0.15% Triton
X-100 in PBS for 5 min for intracellular catalase immunoreactivity, or without Triton X100 for surface catalase immunoreactivity. After washing with 0.1% PBS-BSA, cells
were overlaid with normal rabbit serum (JacksonImmuno Research, West Grove, PA) for
5 min and then washed. Coverslips were then overlaid with primary antibody Ab365 (a
highly specific polyclonal antibody, Center for Integrated BioSystems, Logan, UT) for 30
min (1/1000 in PBS-0.1% BSA), and then incubated for another 30 min (after addition of
more PBS-BSA to prevent drying), washed, and then overlaid with fluorescently-tagged
secondary antibody Alexa Fluor 594 (with excitation at 591 nm and emission at 614 nm)
(JacksonImmuno Research, West Grove, PA) and Phalloidin (Sigma-Aldrich, St. Louis,
MO) labeled with fluorescein isothiocyanate (with excitation at 495 nm and emission at
513 nm) for 30 min. Coverslips were then washed three times. After the final wash, the
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coverslips were placed over mounting media (10% 1 M Tris, 80% glycerol) on a
microscope slide, and sealed for subsequent confocal microscopy analysis. A Nikon TE200 microscope (BioRad) was used for confocal imaging. Images were collected with
ZEN software, using a 60x oil immersion objective and further processed with ImageJ
and Adobe Photoshop CS5.
Western Blots
The isolated intestinal cells described above were collected by centrifugation at
500 x g, 5 min (4ºC), and resuspended in 30 ml of GBSS. 5 ml of the cell suspensions
were combined with test substance in GBSS to give a final concentration of 0.01%
ethanol, 6.5 nM 24R,25(OH)2D3 or 200 pM 24S,25(OH)2D3. The cells were incubated for
10 minutes and 25 minutes, then 1 ml were removed to 10 ml of ice-cold PBS for
cytoplasmic and nuclear extraction. The extraction procedure used a nuclear extract kit
(Active Motif, Carlsbad, CA) according to the instruction manual, which involves mixing
with a series of detergents in the presence of protease inhibitors.
SDS-PAGE and western blot analyses were used to determine immunoreactive
levels of catalase in control and vitamin D treated cells. Protein was determined with the
Bradford reagent (Bio-Rad, Hercules, CA) and then samples (5-30µg/well) were
separated on 8% (wt/vol) SDS-PAGE gels with 5% stacking gels. After separation on
SDS-PAGE, proteins were transferred to polyvinylidene difluoride (PVDF) membranes
(Immobilon-P, Fisher Scientific) by the use of a TransBlot SD Semidry transfer cell (BioRad.) and western analyses were performed. To avoid nonspecific binding, the membrane
was soaked for 1 hr at 37ºC in blocking solution (0.5% nonfat dry milk in phosphate
buffered saline (PBS; 0.9% NaCl and 10 mM Na2HPO4, pH 7.4), followed by washing

42
three times for 5 min each time with washing solution (0.1%(wt/vol) BSA in Trisbuffered saline (TBS; 0.9% NaCl in 20 mM Tris-HCl, pH 7.4), and incubation with
primary antibody (Abcam Inc., Cambridge, MA) overnight at 4ºC in1%BSA and 0.05%
Tween 20 in TBS. After three additional washes, the membrane was incubated with
secondary antibody (alkaline phosphatase-conjugated goat anti-rabbit IgG) in the
antibody incubation buffer described above for 2 hr at room temperature and then washed
as previously indicated. Immunoreactive bands were visualized with the chromogens 5bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium, and relative amounts of
catalase were quantitated using Adobe Photoshop.

Results
Effect of 24,25(OH)2D3 on catalase redistribution in isolated chick enterocytes
In isolated chick enterocytes, 130 pM 1,25(OH)2D3 has been shown to stimulate
phosphate uptake after 5 minutes [3] and 24,25(OH)2D3 was reported to abolish that
effect [19]. In this study, time course experiments on catalase localization in isolated cells
were compared among ethanol control, 1,25(OH)2D3 and 24,25(OH)2D3 treatments. In
initial experiments, catalase localization by confocal microscopy was determined by
adding hormones before primary antibody Ab365 to allow potential redistribution of the
receptor. Chick intestinal cells were cultured in petri dishes, treated with 0.01% ethanol,
6.5nM 24R,25(OH)2D3, 200pM 24S,25(OH)2D3, or 360pM 1,25(OH)2D3, concentrations
that have been shown to be equivalent to circulating levels[20], for selected times (15 sec,
30 sec, 7 min, 10 min, 15 min, 25 min, 30 min, 40 min, 50 min, 60 min), and fixed for
confocal microscopy.

Red staining depicts Alexa Fluor 594 fluorescence, which is
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indicative of catalase localization on the cell surface. Figure 2.1A shows shorter
hormone/ethanol incubation time points and Figure 2.1B shows longer hormone/ethanol
incubation time points. Control cells treated with 0.01% ethanol for selected times
revealed obvious surface staining, with a low level inside the nucleus. These observations
in this and subsequent experiments were reproduced in triplicate experiments. These
results are shown quantitatively in Figure 2.1C, and indicate no significant differences
with time or a slight increase in redistribution was seen with time. Figure 2.2 depicts
results from experiments in which cells were treated with 24R,25(OH)2D3 for shorter
(Figure 2.2A) and longer (Figure 2.2B) time points, in which there were obvious
increases in nuclear staining (indicated by yellow arrows) as well as surface staining
relative to controls. Quantification of nuclear staining is depicted in Figure 2.2C.
Significant differences were observed at 15 seconds after hormone treatment. Figure 2.3
depicts results from experiments in which cells were treated with 24S, 25(OH)2D3 for
shorter (Figure 2.3A) and longer (Figure 2.3B) time points, in which there were slight
increases in nuclear staining relative to controls, but to a much lesser extent compared to
24R,25(OH)2D3 treatment. Figure 2.3C provides quantification of the data, and illustrates
that 24S,25(OH)2D3 treatment caused 100%-111% change in nuclear staining, relative to
cells treated with 24R,25(OH)2D3. Figure 2.4 depicts results from experiments in which
cells were treated with 1, 25(OH)2D3 for shorter (Figure 2.4A) and longer (Figure 2.4B)
time points, in which there were no increases in nuclear staining nor surface staining
relative to controls, since 1,25(OH)2D3 does not compete with 24R,25(OH)2D3 for
binding to catalase. These results are shown quantitatively in Fig. 2.4C. In a previous
study, it was found that 24R,25(OH)2D3 is capable of decreasing phosphate absorption
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after a 1-h injection in vivo and 24S,25(OH)2D3 is capable of increasing phosphate
absorption after a 5-h injection in vivo, suggesting that the inhibitory effect might be
mainly performed by 24R,25(OH)2D3 [21]. One possible gene regulatory mechanism
could be catalase binding to STAT3 [22]. Further study is required to see if STAT3 is a
binding partner of catalase.
The question was raised as to the origin of the nuclear staining. In order to answer
that, additional confocal microscopy experiments were undertaken to determine whether
cell surface catalase was the source of steroid-mediated nuclear redistribution. In these
experiments, primary antibody Ab 365 was first added to cells for 30 min, and
subsequently incubated with ethanol vehicle, 1,25(OH)2D3, 24S,25(OH)2D3, or
24R,25(OH)2D3. Figure 2.5 depicts control cells treated with 0.01% ethanol for shorter
(Figure 2.5A) and longer (Figure 2.5B) time points revealed obvious surface staining, but
little inside the nucleus. As shown in Figure 2.6A and B, nuclear redistribution after
24R,25(OH)2D3 treatment did not occur, suggesting that ligand binding to cell surface
catalase induced redistribution to the nucleus, but was blocked by the primary antibody.
Similarly, treatment of cells with addition of primary antibody before hormone treatment
inhibited the effects of 24S,25(OH)2D3 (Figure 2.7A, and 2.7B), and as expected, no
effect of 1,25(OH)2D3 treatment on catalase localization was found (Figure 2.8A and
2.8B).
To further elucidate the observations above, catalase-staining intensity inside the
nucleus was quantified with ImageJ and Adobe Photoshop CS5 software. Figure 2.9
depicts comparisons among ‘hormones first treatments’—in which cells were treated with
hormones/ethanol vehicle prior to primary antibody Ab 365. There was a significant
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increase (P<0.01) in the intensity within the 24R,25(OH)2D3 treated group, a smaller
increase (P<0.05) in the intensity within the 24S,25(OH)2D3 treated group was also
observed, while the other groups stayed the same. Figure 2.10 depicts a comparison
among cells treated with primary antibody Ab 365 prior to hormones/ethanol, or
‘antibody first treatments’. While blocking the cell surface catalase, there was no obvious
increase in the nuclear staining intensity among the four groups, indicating that the
nuclear redistribution mediated by 24R,25(OH)2D3 is indeed from cell surface catalase.
An independent approach was taken to verify these findings. In these experiments,
cells were treated with either ethanol vehicle, 24S,25(OH)2D3, or 24R,25(OH)2D3 for 10
and 25 min, collected by centrifugation, and resuspended in homogenization buffer for
subcellular fractionation. Aliquots of P1 (nuclei, brush borders, and unbroken cells), P2
(peroxisomes, lysosomes, mitochondria, Golgi, and basal lateral membranes, and S2
(microsomes and cytosol), were subjected to SDS-polyacrylamide gel electrophoresis,
followed by western blotting. The results reproducibly showed more nuclear
redistribution after 24R,25(OH)2D3 treatment compared to 24S,25(OH)2D3 (Figure 2.11).
One possible explanation might be there was a higher concentration of 24R,25(OH)2D3 in
the incubations than 24S,25(OH)2D3. Catalase bands intensity were then quantified using
ImageJ software. Figure 2.12 indicates a significant increase (P<0.01) in catalase band
intensity among 24R,25(OH)2D3 treatments. However, the fact that redistribution from
cell surface and organelles to the nucleus following 24S,25(OH)2D3 was detected by
western analysis indicates that confocal microscopy is the less sensitive method. The
results shown in Figure 2.11 also indicate that the commercially available antibody is less
specific than Ab 365 [17].
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Cells were incubated with vehicle or steroid (24R or 24S) for the indicated
lengths of time. The cells were then collected by centrifugation and the pellets
resuspended in homogenization medium. After disruption in a homogenizer, the cells
were subjected to centrifugation at 1000 x g for 20 min to yield pellet 1 (P1 containing
nuclei, brush borders, and unbroken cells). And the supernatant again centrifuged to yield
pellet 2 (P2 containing basal lateral membranes, Golgi, mitochondria, and lysosomes.
Western analyses were performed with primary antibody from Abcam.
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Figure 2.1 Time course study of catalase localization in isolated intestinal cells: ethanol
control treatment. Figure 2.1A indicates shorter incubation time points (15 sec, 30 sec, 7
min, 10 min, 15 min); Figure 2.1B indicates longer incubation time points (25 min, 30
min, 40 min, 50 min, 60 min). Cells were isolated by citrate chelation, resuspended in
Gey’s balanced salt solution, and pipeted into petri dishes containing a coverslip and
RPMI 1640. Cells were allowed to adhere overnight in the absence of serum at 37ºC with
5% CO2/95% air. The following day, media were replaced with GBSS-0.1% BSA.
Ethanol was then added for the indicated times, after which cells were fixed and stained
with anti-catalase antibody and Alexa Fluor 594 and fluorescein conjugated Phalloidin
(not shown). Cell images were observed and taken using Zeiss Confocal Microscope
LSM 710, 60 x oil objective. Images were edited with ImageJ and Adobe Photoshop
CS5.

48

Figure 2. 2 Time course study of catalase localization in isolated intestinal cells: 6.5 nM
24R,25(OH)2D3 hormone treatment. Cells were isolated, cultured, and stained as
described in the legend to Figure 2.1. Catalase punctate staining inside nucleus is
indicated using a yellow arrow. Figure 2.2A indicates shorter incubation time points (15
sec, 30 sec, 7 min, 10 min, 15 min); Figure 2.2B indicates longer incubation time points
(25 min, 30 min, 40 min, 50 min, 60 min). Figure 2.2C presents a bar graph of intensity
of nuclear staining vs. time. Values represent means ± S.E.M for n =7 independent
experiments. Significant differences (**P<0.01) were determined using the student t-test,
are relative to corresponding controls.
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Figure 2.3 Time course study of catalase localization in isolated intestinal cells: 200 pM
24S,25(OH)2D3 hormone treatment. Figure 2.3A indicates shorter incubation time points
(15 sec, 30 sec, 7 min, 10 min, 15 min); Figure 2.3B indicates longer incubation time
points (25 min, 30 min, 40 min, 50 min, 60 min). Figure 2.3C presents a bar graph of
intensity of nuclear staining vs. time. Values represent means ± S.E.M for n =7
independent experiments. Significant differences (**P<0.01) (*P<0.05) were determined
using the student t-test, are relative to corresponding controls, are relative to
corresponding controls.
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Figure 2.4 Time course study of catalase localization in isolated intestinal cells: 360 pM
1,25(OH)2D3 hormone treatment. Figure 2.4A indicates shorter incubation time points
(15 sec, 30 sec, 7 min, 10 min, 15 min); Figure 2.4B indicates longer incubation time
points (25 min, 30 min, 40 min, 50 min, 60 min). Figure 2.4C indicates catalase nuclear
punctate staining intensity between ethanol control treatment and 1,25(OH)2D3 hormone
treatment. Values represent means ± S.E.M for n =7 independent experiments.
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Figure 2.5 Time course study of catalase localization in isolated intestinal cells: 0.01%
ethanol (final concentration) after prior incubation with antibody. Figure 2.5A indicates
shorter incubation time points (15 sec, 30 sec, 7 min, 10 min, 15 min); Figure 2.5B
indicates longer incubation time points (25 min, 30 min, 40 min, 50 min, 60 min). Cells
were isolated, cultured, and stained as describe in the legend to Figure 2.1.
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Figure 2. 6 Time course study of catalase localization in isolated intestinal cells: 6.5 nM
24R,25(OH)2D3 hormone treatment after prior incubation with antibody. Figure 2.6A
indicates shorter incubation time points (15 sec, 30 sec, 7 min, 10 min, 15 min); Figure
2.6B indicates longer incubation time points (25 min, 30 min, 40 min, 50 min, 60 min).
Cells were isolated and cultured as described in Fig. 2.1 The following day, media were
replaced with primary anti-catalase antibody for 30 min prior to addition of steroid and
the indicated incubation periods. Cells were fixed and stained as described in Figure 2.1.
Figure 2.6C indicates catalase nuclear punctate staining intensity between ethanol control
treatment and 24R,25(OH)2D3 hormone treatment. Values represent means ± S.E.M for n
=7 independent experiments.
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Figure 2. 7 Time course study of catalase localization in isolated intestinal cells: 200 pM
24S,25(OH)2D3 hormone treatment after prior treatment with antibody. Figure 2.7A
indicates shorter incubation time points (15 sec, 30 sec, 7 min, 10 min, 15 min); Figure
2.7B indicates longer incubation time points (25 min, 30 min, 40 min, 50 min, 60 min).
Figure 2.7C presents a bar graph with quantification of the observed nuclear
fluorescence. The following day, media were replaced with primary anti-catalase
antibody for 30 min prior to addition of steroid for the indicated times. Cells were
processed for microscopy as describe in the legend to Figure 2.1. Figure 2.7C indicates
catalase nuclear punctate staining intensity between ethanol control treatment and
24S,25(OH)2D3 hormone treatment. Values represent means ± S.E.M for n=7
independent experiments.
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Figure 2.8 Time course study of catalase localization in isolated intestinal cells: 360 pM
1,25(OH)2D3 hormone treatment after prior treatment with antibody. Figure 2.8A
indicates shorter incubation time points (15 sec, 30 sec, 7 min, 10 min, 15 min); Figure
2.8B indicates longer incubation time points (25 min, 30 min, 40 min, 50 min, 60 min).
Figure 2.8C presents a bar graph depicting quantification of nuclear staining intensity for
the various time points. Cells were isolated and cultured as described in Figure 2.1. The
following day, media were replaced with primary anti-catalase antibody for 30 min. Cells
were fixed and stained with Alexa Fluor 594 and Phalloidin. 1,25(OH)2D3 hormone was
then added for the indicated times. Figure 2.8C indicates catalase nuclear punctate
staining intensity between ethanol control treatment and 1,25(OH)2D3 hormone
treatment. Values represent means ± S.E.M for n = 7 independent experiments.
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Figure 2. 9 Western analyses on effect of vitamin D and time on catalase expression in
the nucleus. Cells were isolated and nuclei extracted using nuclear extract kit. Anticatalase was used as the primary antibody. 10µg of protein was loaded for each lane.
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Figure 2.10 Western blot of nuclear extract catalase band intensity quantified by ImageJ
software. Values represent means ± S.E.M for n =3 independent experiments. Significant
differences (*P<0.05; ** P<0.01) were determined using Student’s t-test, are relative to
corresponding ethanol controls, and are indicated by an asterisk.
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Discussion
In this study, localization of catalase inside chick intestinal cells was determined
using confocal microscopy. Figure 2.1 depicts no redistribution of catalase in vehicle
ethanol control treatments after 15 sec to 60 min incubation. Figure 2.2 indicates an
obvious catalase redistribution to nucleus at every indicated incubation time point in
24R,25(OH)2D3 treatments. Figure 2.3 depicts no obvious redistribution of catalase in
24S,25(OH)2D3 treatments, the same observation can be found in Figure 2.4, where no
redistribution of catalase was found after 1,25(OH)2D3 treatment. In order to test whether
the observed redistribution of catalase to the nucleus after 24R,25(OH)2D3 treatments are
from the cell surface, another set of experiments were undertaken. On the day of the
experiments, primary antibody was added to the cells before treatment with vehicle or
hormones to block internalization of cell surface catalase.

Figure 2.5 depicts no

redistribution of catalase in vehicle control treatments after 15 sec to 60 min of
incubation. In Figure 2.6, no catalase redistribution is observed at any indicated
incubation time point in 24R,25(OH)2D3 treatment, which indicates that adding primary
antibody prior to 24R,25(OH)2D3 treatment completely abolishes the effect. In Figure 2.7
and 2.8, no redistribution of catalase was observed either after 24S,25(OH)2D3 or
1,25(OH)2D3 treatment. In order to quantify the catalase punctate staining intensity, each
image was edited and quantified using Adobe Photoshop CS5. As indicated in with each
figure, when vehicle control or hormones were added prior to primary antibody, a
significant increase (200%, P<0.01) in the nuclear punctate staining intensity is observed
in 24R,25(OH)2D3 treatments, compared to vehicle control treatments as well as
1,25(OH)2D3 treatment [190%, increase of 24R,25(OH)2D3 relative to 1,25(OH)2D3]. An
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increase in the punctate staining intensity is also observed in 24S,25(OH)2D3 treatments,
but to a lesser extent (130% relative to ethanol control; 110% relative to 1,25(OH)2D3
treatment; P<0.05). When vehicle control or hormones are added after primary antibody
addition, as indicated in Figure 2.10, all four treatments (vehicle control, 24R,25(OH)2D3,
24S,25(OH)2D3, and 1,25(OH)2D3 treatment) share the same pattern. No significant
difference is observed among the four treatment groups, indicating cell surface catalase is
required as the receptor for redistribution. Western analyses were undertaken to further
prove the hypothesis tested above. In Figure 2.11, a denser band was observed in the
nuclear extract sample in both 24R,25(OH)2D3 and 24S,25(OH)2D3 treatments, relative to
vehicle controls. As indicated in Figure 2.12, catalase band intensity was quantified by
ImageJ software. There is a significant increase in the band intensity after
24R,25(OH)2D3 treatment (300%, P<0.01) and a slight increase in the band intensity after
24S,25(OH)2D3 treatment (140%, P<0.05), which is in agreement with the results from
experiments above.
The combined data indicate that 24,25(OH)2D3 treatment of intestinal cells results
in the migration of cell surface catalase to the nucleus. This in turn strongly suggests that
24R,25(OH)2D3 has effects on the genome in addition to the reported rapid effects on
phosphate transport. Microarray analyses may in the future identify particular genes or
groups of genes that are modulated by 24,25(OH)2D3.
Taken together, these results suggest that the changes in catalase localization that
occur during the time points tested with 24R,25(OH)2D3 treatment may have potential
clinical significance in phosphate homeostasis and in the development of the
development of pharmacological therapies.
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CHAPTER 3
EFFECTS OF VITAMIN D ON CATALASE EXPRESSION AND PHOSPHATE
UPTAKE IN CHICKEN INTESTINAL CELLS

Abstract
Many researchers now recognize that the steroid 24,25-dihydroxyvitamin D3
[24,25(OH)2D3] has biological activity. In previous work from our lab, it has been
reported that 24,25(OH)2D3 decreases catalase protein levels in cultured intestinal cells
over a period of several hours. An effect on catalase gene expression combined with
rapid signaling would conclusively demonstrate that 24,25(OH)2D3 is not a ‘scrap’
metabolite. In the current work, we report that 24R,25(OH)2D3 is the effective metabolite
for decreasing 32P uptake and catalase gene expression, but not for protein regulation. We
have used male chick intestinal cells treated with either vehicle, 24,25(OH)2D3 or
1,25(OH)2D3 for each condition.

32

P uptake assays showed a decrease in uptake after

24R,25(OH)2D3 treatment in both suspension cells and cultured cells. RT-PCR further
indicated a down-regulation of catalase gene expression after treatment with
24R,25(OH)2D3 compared to vehicle control and 1,25(OH)2D3. Protein expression was
then checked using western blotting, with a result of no change in protein expression
levels. By understanding molecular and cellular actions of 24,25(OH)2D3 in chick
intestine, progress will be made in enhancing phosphate and calcium absorption in
animals to supply the minerals for adequate bone growth, and cellular metabolism.
Introduction
1,25-Dihydroxyvitamin D3 [1,25(OH)2D3], the most studied vitamin D metabolite, exerts
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its effect through both genomic and non-genomic (more accurately termed pre-genomic)
mechanisms. Non-genomic actions are rapid, regulated by membrane-associated
receptors [1] and signal transduction pathways, while genomic actions take longer, and
are exerted largely through transcription family factors to control gene expression [2].
Another vitamin D metabolite, 24,25(OH)2D3, is produced mainly when an animal is
calcium, phosphate, and 1,25(OH)2D3 replete. The inhibitory action of 24,25(OH)2D3 on
phosphate absorption is observed across species. It has been reported that 24,25(OH)2D3
inhibits the rapid 1,25(OH)2D3-mediated stimulation of 32P transport in the perfused chick
duodenal loop [3, 4], as well as 45Ca transport [5]. Catalase, which has been identified as
an endogenous 24,25(OH)2D3 binding protein [6], is in part bound to the cell surface. It
has been reported that 24R,25(OH)2D3, not 24S,25(OH)2D3, is the effective metabolite
for catalase redistribution [7]. In earlier work we also found that 24,25(OH)2D3 decreases
catalase protein levels in cultured intestinal cells over a period of several hours [8].
In the current study we report that in intestinal cells 24R,25(OH)2D3 decreased 32P
uptake and catalase gene expression after 7 min treatment at the mRNA level. As mRNA
levels cannot be used as surrogates for corresponding protein levels without verification
[9], we performed western blotting to confirm the relation, with a result of no change in
protein expression.

Experimental
Animals
All surgical procedures were approved by the Institutional Animal Use and Care
Committee at Utah State University (Logan, UT). White leghorn cockerels (Privett
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Hatchery; Portales, NM) were obtained on the day of hatch and raised for 3-7 weeks on a
commercially available vitamin D-replete diet (Nutrena Feeds; Murray, UT). On the day
of use, chicks were anesthetized with anhydrous ethyl ether (Fisher Scientific, Fair Lawn,
NJ). The abdominal cavity was surgically opened and the duodenal loop was removed to
ice-cold 0.9% saline solution and chilled for 15 min. The pancreas was excised from the
duodenal loop and discarded. The duodenal loop was everted and rinsed three times in
chilled saline solution.
Cell Isolation and Cell Culture
The chick enterocytes were isolated with citrate chelation media (96 mM NaCl,
27 mM sodium citrate, 1.5 mM KCl, 8 mM KH2PO4, 5.6 mM Na2HPO4, pH 5.0 – (the
acidic pH promotes viability and retention of morphology[3, 10-12]). The cells were
collected by low speed centrifugation (500 x g, 5 min, 4ºC), and cell pellets were
resuspended in a small volume of Gey’s balanced salt solution (GBSS, containing 119
mM NaCl, 4.96 mM KCl, 0.22 mM KH2PO4, 0.84 mM NaHPO4, 1.03 mM MgCl2•6H2O,
0.28 mM MgSO4•7H2O, 0.9 mM CaCl2, pH 7.3). Aliquots of the cell suspension were
pipetted into 35 mm plastic Petri dishes (Falcon, Scientific Products, Franklin Lakes, NJ)
containing 2 ml RPMI-1640 (Hyclone; Logan, UT) and antibiotics (100 units/ml
penicillin, 100mg/ml streptomycin; Sigma-Aldrich Chemical Company, St. Louis, MO).
The cells were incubated overnight or longer at 37ºC with 5% CO2/ 95% air in the
absence of serum to promote cell adhesion.
32

P uptake in suspension and cultured intestinal cells
Chick intestinal cells were isolated by citrate chelation as described above and

centrifuged at low speed (500 x g, 5 min, 4ºC). Cell pellets were resuspended in room
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temperature Gey’s Balanced Salt Solution. 2.2 mL of cell suspensions were pipetted into
a polypropylene tube along with 1 µCi/ml (1 Ci = 37 GBq) H332PO4, final concentration
(Perkin Elmer, Boston, MA). 100 µl of cell suspensions were removed at T = -5 and -1
min to establish basal uptake. At T = 0 min, cells were treated with either vehicle (0.01%
ethanol, final concentration), 300 pM 1,25(OH)2D3, 6.5 nM 24R,25(OH)2D3 or 200 pM
24S,25(OH)2D3, and incubated at room temperature. At T = 1, 3, 5, 7, 10 min, 100 µl of
cell suspension aliquots were transferred to 900 µl ice-cold GBSS in 1.5 ml
microcentrifuge tubes to stop phosphate uptake. Samples were put on ice until
centrifuged at 1000 x g for 5 min, 4ºC. Supernatant was decanted and any residual liquid
was carefully swabbed with Kimwipes while still in the inverted position. Pellets were
resuspended in 500 µl double distilled water, aliquots were used for protein determination
using a UV spectrophotometer (Beckman Coulter) and radionuclide measurement using a
multi-purpose scintillation counter (Beckman) [8]. Values obtained for the treated phase
were normalized to average basal phase, and represent means ± S.E.M for n independent
experiments. Time course data indicated that optimal responsiveness to 24,25(OH)2D3
occurred at 7 min of steroid treatment.
Chicken intestinal cells were isolated by the citrate chelation protocol as
previously described. Under sterile conditions, 200 µl aliquots of cell suspension were
pipetted into 35 mm plastic Petri dishes (Falcon, Scientific Products) containing 3 ml of
RPMI-1640 medium and antibiotics [100 units/ml penicillin, 100 mg/ml streptomycin
(Sigma Chemical Co, St. Louis, MO)]. The cells were incubated overnight with 5%
CO2/95% air at 37ºC. No serum was added to promote better cell adherence.
The next day, media were aspirated and cells were pre-incubated at room
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temperature for 5 min in 1 ml GBSS-0.1%BSA. Then 1 ml of GBSS-0.1%BSA
containing 4 µCi of H332PO4 with either 300 pM 1,25(OH)2D3, 200 pM 24S,25(OH)2D3
or 6.5 nM 24R,25(OH)2D3 were added and incubated for an additional 7 min. Adherent
cells were washed three times with 4 ml ice-cold GBSS and lysed with 0.5 ml 0.1% (v/v)
Triton X-100 in TED. Finally, cells were collected by scrapping and aspirating. Aliquots
were used for protein determination using a UV spectrophotometer (Beckman Coulter,
City State) and radionuclide measurement using a multi-purpose scintillation counter
(Beckman) [8]. Values represent means ± S.E.M for N independent experiments.
siRNA transfection in cultured intestinal cells
Chicken intestinal cells were isolated by the citrate chelation protocol as
previously described. Under sterile conditions, 200 µl aliquots of cell suspension were
pipetted into 35 mm plastic Petri dishes (Falcon Scientific Products; Franklin Lakes, NJ)
containing 2 ml of RPMI-1640 medium and antibiotics [100 units/ml penicillin, 100
mg/ml streptomycin (Sigma Chemical Co; St. Louis, MO)]. The cells were incubated
overnight with 5% CO2/95% air at 37ºC prior to transfection. No serum was added to
promote better cell adherence.
The next day, cells were transfected with 100 nM scrambled siRNA (Santa Cruz
Biotechnology; Santa Cruz, CA), or 80 pmols siRNA against catalase, under RNase-free,
sterile conditions. Cells were then incubated 5-7 hours at 37ºC in a CO2 incubator. 1 ml
of normal growth medium containing 2 times the normal serum and antibiotic
concentration (2x normal growth medium) were added without removing the transfection
mixture. After another additional 18-24 hours incubation, media were aspirated and
replaced with RPMI-1640 with 10% FBS. The following procedures were conducted
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after 24 hours of addition of fresh medium.
Western Blots
The isolated intestinal cells described above were collected by centrifugation at
500 x g, 5 min (4ºC), and resuspended in 30 ml of GBSS. Cells were then cultured
overnight, then transfected the next day according to the siRNA transfection protocol
(Santa Cruz). On the day of use, cells were treated with 0.01% ethanol, 6.5 nM
24R,25(OH)2D3 or 300 pM 1,25(OH)2D3 for 7 min at room temperature. Media was
removed and cells were lysed with 0.5 ml 0.1% (v/v) Triton X-100 in TED. 10µg of total
protein were loaded in each lane.
SDS-PAGE and western blot analyses were used to determine immunoreactive
levels of catalase in controls and cells treated with vitamin D metabolites. Protein was
determined with the Bradford reagent (Bio-Rad, Hercules, CA) and then samples (530µg/well) were separated on 8% (wt/vol) SDS-PAGE gels with 5% stacking gels. After
separation on SDS-PAGE, proteins were transferred to polyvinylidene difluoride (PVDF)
membranes (Immobilon-P, Fisher Scientific) by the use of a TransBlot SD Semidry
transfer cell (Bio-Rad) and western analyses were performed. To avoid nonspecific
binding, the membrane was soaked for 1 hr at 37ºC in blocking solution (0.1% wt/vol
BSA) in Tris-buffered saline (PBS; 0.9% NaCl in 20 mM Tris-HCl, pH 7.4), and
incubation with primary antibody (Abcam Inc., Cambridge, MA) in 1% BSA and 0.05%
Tween 20 in PBS overnight at 4ºC. After three additional washes, the membrane was
incubated with secondary antibody (alkaline phosphatase-conjugated goat anti-rabbit
IgG) in the same incubation buffer for 2 hr at room temperature and then washed as
previously indicated. Immunoreactive bands were visualized with the chromogens 5-
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bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium, and relative amounts of
catalase were quantitated using ImageJ software.
RNA isolation and RT-PCR using SYBR green
On the day of use, total RNA was isolated with TRIzol reagent (Sigma) using
glycogen as a carrier because of low cell numbers (<104). For RT-PCR, 100 ng of total
RNA was used for RT reactions to make cDNA. The primer for the 259-bp catalase
product in the forward direction was a 23-mer (5’-CTG GCA ACC CAA TAG GAG
ATA AG-3’), and for the reverse direction, (5’-GCA ACA GTG GAG AAC CGT ATA
G-3’), a 22-mer was used. The primer for the 545-bp GAPDH product in the forward
direction was a 20-mer (5’-AGT CGG AGT CAA CGG ATT TG-3’), and for the reverse
direction, (5’-TCT TCT GTG TGG CTG TGA TG-3’), a 20-mer was used. The primers
were validated using end point PCR, with subsequent experiments using real time PCR.
Power SYBR Green PCR Master Mix (Applied Biosystems, UK) was used for RT-PCR.
The RT-PCR detection procedure was the MiniOpticon System (Bio-Rad) and results
were analyzed with the company’s software.
Determination of Protein Concentration
The Bradford assay was performed to determine sample protein concentrations.
After homogenization of cells, 10 µl of sample was added to 790 µl double distilled water
followed by 200 µl of Bradford reagent (Bio-Rad,). The contents were mixed, set at room
temperature for 10 min for color development, and analyzed by spectrophotometry at 595
nm. Bovine gamma globulin (Sigma) was used as the standard.

69
Statistical Analysis
Values are expressed as the means ± S.E.M for the number of independent
experiments indicated in the figure legends. The data were analyzed for significance
using Student’s t-test and significant and differences were determined with a 95%
confidence level (P<0.05).
Results
Time course study of 32P uptake after hormone treatments in intestinal cells suspensions
Uptake studies in suspension were first undertaken to determine an optimal time
point of hormone effect prior to studies using cultured adherent cells, which are
technically more difficult. Chick intestinal cells were isolated with citrate chelation media
described above and resuspended in 40 mL GBSS, aliquoted, and then treated with 0.01%
ethanol, 130 pM 1,25(OH)2D3, or 6.5 nM 24,25(OH)2D3 with 1 µCi 32H3PO4/1 ml of cell
suspension at room temperature. The selected steroid concentrations have been shown to
be equivalent to circulating levels [13]. Incubations were for selected times (1min, 3min,
5min, 7min, 10min), and uptake stopped by transferring aliquots of cell suspension into
ice-cold GBSS at the indicated times. Cells were pelleted by low speed centrifugation
(1000 x g, 5 min, 4ºC), supernatants decanted, and any residual GBSS was carefully
swabbed with Kimwipes while the tubes were still in an inverted position. Cells were
resuspended in 0.5 ml reagent grade water, and aliquots were taken for determination of
protein and measurement of radionuclide. Figure 3.1 illustrates
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P uptake levels with

different hormone treatment conditions. As shown, 1,25(OH)2D3 had an overall
stimulatory effect on 32P uptake, 24R,25(OH)2D3 had an inhibitory effect on 32P uptake,
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while 24S,25(OH)2D3 had no change relative to the ethanol control treatment. As
illustrated in Figure 3.1, both 1,25(OH)2D3 and 24R,25(OH)2D3 hormone treatments led
to significant changes: 1,25(OH)2D3 at T = 7 min with a 140% increase (P < 0.01) and
for 24R,25(OH)2D3 at T = 7 min with an 136 percent decrease, each relative to vehicle
controls (P < 0.01). The 7 min time point was then chosen for the rest of the study.
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Figure 3.1 - Time course of 1,25(OH)2D3, 24R,25(OH)2D3 or 24S,25(OH)2D3 - mediated
32

P uptake in chicken intestinal cell suspensions, relative to vehicle controls. Cells were

isolated with citrate chelation media, and collected by low speed centrifugation (500 x g,
5 min, 4ºC), cell pellets were resuspended in room temperature Gey's Balanced Salt
Solution (GBSS). Cells were treated with 360 pM 1,25(OH)2D3, 6.5 nM 24,25(OH)2D3 or
vehicle (0.01% ethanol, final concentration) with 1 µCi 32H3PO4/1 ml of cell suspension
at room temperature and stopped by transferring aliquots of cell suspension into ice-cold
GBSS at the indicated times. Cells were pelleted by low speed centrifugation (1000 x g, 5
min, 4ºC), supernatants decanted, and any residual GBSS was carefully swabbed with
Kimwipes while the tubes were still inverted. Cells were resuspended in 0.5 ml reagent
grade water, and aliquots were taken for determination of protein and measurement of
radionuclide. Data were calculated as cpm/µg protein and then related to corresponding
basal levels. Values represent mean ± S.E.M for n=5 independent experiments.
Significant differences (*P<0.05, **P<0.01) were determined using Student’s t-test, are
relative to corresponding controls.
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Effect of P uptake after different hormone treatments at 7 min in cultured intestinal cells
Chick intestinal cells were isolated with citrate chelation media and resuspended
in 40 mL GBSS and cultured overnight as described above. The next morning, cells were
pre-incubated at room temperature for 5 min in 1 ml GBSS-0.1%BSA. Then 1 ml of
GBSS-0.1%BSA containing 4 µCi of H332PO4 with one of three hormones was added and
the cells incubated for an additional 7 min. Adherent cells were washed three times with
4 ml ice-cold GBSS and lysed with 0.5 ml 0.1% (v/v) Triton X-100 in TED. Finally, cells
were collected by scrapping and aspirating, and aliquots were taken for determination of
protein and measurement of radionuclide. Figure 3.2 shows

32

P uptake after treatments

with different hormones or vehicle. According to Figure 3.2, a similar pattern is observed
as in Figure 3.1: 1,25(OH)2D3 had a stimulatory effect on 32P uptake to 220 % of vehicle
controls (P<0.05), 24R,25(OH)2D3 had an inhibitory effect to 140% of vehicle controls
(P<0.05), while 24S,25(OH)2D3 had no effect under these conditions. Thus treatment of
adherent cells in culture gave results equivalent to those in suspension, allowing further
studies with siRNA.
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Figure 3.2 Effect of vehicle, 1,25(OH)2D3 or 24,25(OH)2D3 on

32

P uptake in cultured

chicken intestinal cells. On the days of experiments, cells cultured overnight were preincubated at room temperature for 5 min in 1 ml GBSS-0.1%BSA. Then 1 ml of GBSS0.1%BSA containing 4 µCi of H332PO4 with vehicle, 1,25(OH)2D3, 24S,25(OH)2D3 or
24R,25(OH)2D3 were added and incubated for an additional 7 min. Adherent cells were
washed three times with 4 ml ice-cold GBSS and lysed with 0.5 ml 0.1% (v/v) Triton X100 in TED. Finally, cells were collected by scraping and aspirating, and aliquots were
taken for determination of protein and measurement of radionuclide. Data were
calculated as cpm/µg protein and then related to corresponding vehicle controls. Values
represent means ± S.E.M for n = 8 independent experiments. Significant differences were
determined using the student t-test, and are indicated by an asterisk (*P<0.05, relative to
vehicle control; ** P<0.01, relative to vehicle control).
The lack of effect by 24S,25(OH)2D3 suggested that no further testing with this
metabolite need be performed.
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Effect of vitamin D on cultured chicken enterocytes on catalase gene expression
Chick enterocytes were isolated, cultured, and transfected as described above.
Assays were performed 24 hours after the addition of fresh medium. Total RNA was
prepared with TRIzol reagent, 100 ng was used for cDNA synthesis and 100 ng was used
for RT-PCR with primers specific for catalase or GAPDH as described above. Figure 3.3
provides data as a fold ratio normalized to GAPDH expression. Cells were treated with
test substance for 7 min. siRNA transfection had no effect on gene transcription levels in
cells treated with ethanol or 1,25(OH)2D3 compared to those treated with scramble RNA
(Figure. 3.4). This finding suggests that catalase siRNA treatment was not effective in
reducing catalase expression. However, comparisons between the scrambled siRNA
treatments reveal that 1,25(OH)2D3 increased catalase gene expression relative to ethanol
treatment controls (P<0.01). Conversely, 24R,25(OH)2D3 decreased catalase gene
expression (P<0.01) compared to the ethanol control. When treated with scrambled
control siRNA, the 1,25(OH)2D3 treatment group showed an increase in catalase mRNA
expression relative to ethanol controls, while the 24R,25(OH)2D3 treatment group had a
decrease in catalase mRNA expression, relative to ethanol controls (Figure 3.4).

75

Figure 3.3 Effect of vitamin D on gene expression for catalase in cultures of chicken
intestinal cells. Cells were transfected with scrambled siRNA or catalase siRNA
according to siRNA transfection protocol (Santa Cruz, CA). After transfection, cells were
incubated with ethanol control or test hormones at room temperature for 7 min. Total
RNA was prepared with the TRIzol reagent, and 100 ng was used for RT-PCR with
primers specific for catalase or GAPDH. Values represent means ± S.E.M for n=6
independent experiments. Significant differences were determined using Student's t-test
(**P<0.01).
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Effect of
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P uptake after different hormone treatments at 7 min in cultured transfected

enterocytes
Chick enterocytes were isolated with citrate chelation media and resuspended in
40 mL GBSS cultured overnight at 37ºC with 5% CO2/ 95% air to promote cell adhesion.
The next day, cells were transfected with either scrambled control siRNA or siRNA
directed against catalase according to the siRNA transfection protocol, and were
incubated for an additional 20 hours at 37ºC with 5% CO2/ 95% air. Assays were
performed 24 hours after the addition of fresh medium. Cells were pre-incubated at room
temperature for 5 min in 1 ml GBSS-0.1%BSA. Then 1 ml of GBSS-0.1%BSA
containing 4 µCi of H332PO4 with vehicle or hormones were added and incubated for an
additional 7 min. Adherent cells were washed three times with 4 ml ice-cold GBSS and
lysed with 0.5 ml 0.1% (v/v) Triton X-100 in TED. Finally, cells were collected by
scraping and aspirating, and aliquots were taken for determination of protein and
measurement of radionuclide. Although as demonstrated in Figure 3.4, catalase siRNA
was ineffective in reducing catalase expression; comparisons between the scramble
treated cells revealed that treatment with 1,25(OH)2D3 increased 32P uptake (P<0.01) and
24R,25(OH)2D3 reduced 32P uptake (P<0.01) relative to ethanol controls.
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Figure 3.4 Effect of vehicle, 1,25(OH)2D3 or 24R,25(OH)2D3 on 32P uptake in transfected
cultured chicken enterocytes. Cells were transfected with scrambled control siRNA or
catalase siRNA according to the siRNA transfection protocol (Santa Cruz Biotechnology,
CA). On the day of the experiments, transfected cells were pre-incubated at room
temperature for 5 min in 1 ml GBSS-0.1%BSA. Then 1 ml of GBSS-0.1%BSA
containing 4 µCi of H332PO4 and either vehicle or 1,25(OH)2D3, 24S,25(OH)2D3 or
24R,25(OH)2D3 were added and incubated for an additional 7 min. Adherent cells were
washed three times with 4 ml ice-cold GBSS and lysed with 0.5 ml 0.1% (v/v) Triton X100 in TED. Finally, cells were collected by scraping and aspirating, and aliquots were
taken for determination of protein and measurement of radionuclide. Data were
calculated as cpm/µg protein and then related to corresponding basal levels. Open bars
represent data from scrambled siRNA treatments; Filled bars represent data from siRNA
treatments. Values represent means ± S.E.M for n =4 independent experiments.
Significant differences (**P<0.01) were determined using Student’s t-test, are relative to
corresponding treatments also transfected with scramble RNA.
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Effect of vitamin D on protein expression of catalase in cultured chicken enterocytes
Chick enterocytes were isolated, cultured, and transfected as described above.
Assays were performed 24 hours after the addition of fresh medium. Cells were preincubated at room temperature for 5 min in 1 ml GBSS-0.1%BSA. Then 1 ml of GBSS
containing vehicle or hormones were added and incubated for additional 7 min. Adherent
cells were washed, lysed, and collected as described. 10 µg of protein for each treatment
was used for SDS-PAGE and western blotting. Protein band intensity was determined
using ImageJ software. Figure 3.5 shows no change in protein expression among control
treatments. In contrast, 1,25(OH)2D3 increased catalase protein levels, relative to ethanol
treated controls transfected with scramble siRNA (P<0.01), while 24R,25(OH)2D3,
decreased catalase expression compared to 1,25(OH)2D3 (P<0.05) and ethanol controls.
This result indicated that protein levels are not proportional to mRNA in cultured chicken
enterocytes after 7 min treatment with vitamin D.
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Figure 3.5 Effect of vitamin D on protein levels of catalase in cultured chicken
enterocytes. Cells were transfected with scrambled siRNA or catalase siRNA according
to siRNA transfection protocol (Santa Cruz, CA). Treatment with vehicle or hormones
was for 7 min. Cells were lysed with 0.5 ml 0.1% (v/v) Triton X-100 in TED, 10 µg of
proteins were used for SDS-PAGE and western blotting. Figure 3.5A shows a western
blot; Figure 3.5B depicts densitometric analyses of the bands shown. Values represent
means ± S.E.M for n=3 independent experiments. Significant differences were
determined using the student t-test, are relative to corresponding controls, and are
indicated by asterisks (**P<0.01) (*P<0.05).
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Discussion
Previous experiments with primary cultures of chick intestinal cells exposed to
24,25(OH)2D3 for 5 h have demonstrated that 24R,25(OH)2D3 is capable of decreasing
both catalase specific activity and catalase protein levels [8]. In this study with suspended
chick enterocytes treated with 24R,25(OH)2D3, a decrease in phosphate uptake occurs as
early as 1 min and is significantly lower than ethanol controls at 7 min. Although the
treated/average basal values increase in both 24S,25(OH)2D3 and 24R,25(OH)2D3 with
time, 24S,25(OH)2D3 remained more closely to basal values compared to
24R,25(OH)2D3. In contrast, the decrease in
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P uptake is sustained at an average of

150% below controls from 1 to 10 min in 24R,25(OH)2D3 treatments. A similar result is
observed with primary cultured chick enterocytes. After a 7 min incubation with
hormones or the vehicle ethanol (a time point determined by previous study in cell
suspension), a significant decrease in phosphate uptake is observed in 24R,25(OH)2D3
treatments (at an average of 140% below ethanol controls).
With equivalent results observed in both suspension and cultured chick
enterocytes, further siRNA study was undertaken to determine whether this manipulation
affects 24R,25(OH)2D3 mediated changes in catalase gene expression and/or protein
expression. Unfortunately, catalase siRNA treatment was not effective in reducing
catalase gene expression. Nonetheless, several important observations were made. A
decrease in 1,25(OH)2D3-mediated phosphate uptake is observed with a 7 min after
24R,25(OH)2D3 treatment combined with scrambled siRNA (P<0.01). An increase in
1,25(OH)2D3-mediated phosphate uptake is observed with 7 min after 1,25(OH)2D3
treatment combined with scrambled siRNA (P<0.01). Catalase gene expression was
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determined using RT-PCR, and a significant 281% decrease is observed in
24R,25(OH)2D3 treated cells with scramble siRNA relative to the corresponding ethanol
control (P<0.01). The inhibitory effect was again diminished with catalase siRNA.
Protein levels of catalase were determined by western blots after 7 min of steroid
treatment. With catalase antibody directed against chick catalase as primary antibody,
fainter bands were observed in cultured cells treated with 24R,25(OH)2D3, while
1,25(OH)2D3 treatment produced denser bands (Figure 3.5A). Densitometric analysis
(Figure 3.5B) indicated a significantly lower level of immunoreactive protein in cultured
intestinal cells treated for 7 min with 24R,25(OH)2D3, relative to either corresponding
control or 1,25(OH)2D3 treatments (P<0.01). This observation is in agreement with
similar effect observed in 24 h samples for chick intestinal cells and kidney cells [8].
These combined data indicated that 24R,25(OH)2D3 has significant physiological
consequences in maintaining phosphate homeostasis even though the siRNA did not
work in manipulating catalase gene expression in cultured chick enterocytes.
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CHAPTER 4
SUMMARY AND CONCLUSIONS

Summary
1,25-dihydroxyvitamin D3 has proven to be the up-regulating steroid hormone for
phosphate homeostasis. This secosteroid hormone exerts its effect through two different
mechanisms, either via a nuclear vitamin D receptor (nVDR) to express a slow action to
generate genomic responses or through the more rapid action of 1,25D3-MARRS receptor
to generate pre-genomic actions of ion transport and signal transduction inside cells [1-6].
From previous studies, it was demonstrated in chick enterocytes that the signal
transduction mechanism of 1,25(OH)2D3-mediated rapid uptake of phosphate was
mediated by PKC [7, 8].
Catalase has been proven to be the cellular binding protein for 24,25dihydroxyvitamin D3 [24,25(OH)2D3] [9]. Both 24,25(OH)2D3 and the production of
H2O2 have been demonstrated to inhibit catalase activity [10]. Somjen et al. [11] reported
that 24R,25(OH)2D3, not 24S,25(OH)2D3 was the active metabolite in bone. However, a
previous study found that the two isomers of 24,25(OH)2D3 had different effects on
phosphate transport in vivo [12]. The inhibitory effect is mainly performed by
24R,25(OH)2D3 since it was capable of decreasing phosphate absorption after a 1h
injection in vivo, while 24S,25(OH)2D3 was found to be increasing phosphate transport at
5h in chicks in vivo but the latter effect was diminished after 10h. This suggests another
receptor may be involved, or that the steroid may stimulate other pathways to mediate
phosphate absorption in vivo [12]. Previous work done in the perfused duodenal loop
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system has proved that the antagonism of the stimulatory effect of 1,25(OH)2D3 by
24,25(OH)2D3 was seen 10 min after the onset of perfusion [13]. In these studies, the
main focus was on how 24,25(OH)2D3 effects phosphate uptake in chick enterocytes in
vitro.
The first series of experiments were performed to determine the effects of the two
isomers of 24,25(OH)2D3 on localization of catalase in chick enterocytes. The present
work demonstrated that 24R,25(OH)2D3 is the effective metabolite for catalase
redistribution in vitro, not 24S,25(OH)2D3. Male chick intestinal cells were treated with
either vehicle, 24R,25(OH)2D3 or 1,25(OH)2D3, and punctate staining was observed on
the cell surface and in the cytoplasm for all time points tested. Figure 2.2 depicts results
from 24R,25(OH)2D3 treatments, in which there were obvious increases in nuclear
staining as well as surface staining relative to controls (Figure 2.1). Figure 2.3 shows
results from 24S,25(OH)2D3 treatments, in which there was an obvious decrease in
punctuate nuclear staining compared to 24R,25(OH)2D3 treatments. Additional western
analyses were performed to confirm the punctate staining inside the nucleus was from the
redistribution of cell surface catalase.
Further experiments were undertaken to examine the origin of the nuclear staining
by confocal microscopy experiments. Primary antibody was first added to cells for 30
min in order to block surface staining, and subsequently incubated with vehicle,
1,25(OH)2D3, 24R,25(OH)2D3 or 24S,25(OH)2D3. This work demonstrated that ligand
binding to cell surface catalase induced redistribution to the nucleus, but was blocked by
the antibody. Figure 2.6 indicates nuclear redistribution after 24R,25(OH)2D3 treatment
did not occur, indicating that the cell surface catalase induced redistribution was blocked
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by the antibody. A similar effect was not found in either 24S,25(OH)2D3 nor control
treatments. Catalase punctate staining intensity was also quantified by densitometry.
The second series of experiments were performed to determine the relationship
between vitamin D metabolites, catalase expression and phosphate uptake in chicken
intestinal cells. It has been reported that 24,25(OH)2D3 decreases catalase protein levels
in cultured intestinal cells over a period of several hours [14], an effect on catalase gene
expression combined with rapid signaling would conclusively demonstrate that
24,25(OH)2D3 is not a ‘scrap’ metabolite. The present work demonstrated that
24R,25(OH)2D3 is the effective metabolite for decreasing phosphate uptake and catalase
gene expression, not 24S,25(OH)2D3. Figure 3.1 and Figure 3.2 illustrates

32

P uptake

levels with different hormone treatment conditions in normal enterocytes, in which
24R,25(OH)2D3 has a inhibitory effect on phosphate uptake, while 24S,25(OH)2D3 does
not. Figure 3.3 demonstrates the effect of different hormone treatments on 32P uptake in
transfected cultured enterocytes. A decrease in 32P was observed only in 24R,25(OH)2D3
treatment (P<0.05), indicating an elimination of the steroid-catalase effect on decreasing
phosphate uptake. As shown in Figure 3.4, only 24R,25(OH)2D3 treatment led to a
decrease in catalase mRNA expression. It was also determined that 24R,25(OH)2D3 had
no effect on catalase protein expression.
Conclusions
From these recent results, we can then conclude that:
1. 24R,25(OH)2D3, not 24S,25(OH)2D3, is the effective metabolite for catalase
redistribution in chicken enterocytes in vitro.
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2. Western analysis and additional confocal microscopy experiments confirmed that the
punctate staining inside the nucleus arose from the redistribution of cell surface
catalase.

3. 24R,25(OH)2D3 is the effective metabolite for decreasing phosphate uptake as well as
catalase gene expression determined by RT-PCR, but did not have an effect on protein
expression as determined by western analysis.
Future Study
1. Determination of the possible mechanism involved in catalase binding to STAT3 [15];
2. Evaluation of whether 24R,25(OH)2D3 mediates the production of separate hormones
that regulate phosphate transport.
Benefit
This study provides some basic framework of cellular and molecular mechanism
of 24,25(OH)2D3 regulated phosphate homeostasis, and increases our understanding of
the effects of 24,25(OH)2D3 on phosphate transport in vitro. The results from this
research may open new ways for drugs or gene therapies to regulate phosphate
homeostasis. Furthermore, this research also has implications in agriculture. Since the
production of manure high in phosphate in poultry farms is a serious problem, phosphate
in manure of production animals could be diminished.
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